Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
32.20
-0.30 (-0.92%)
Jul 30, 2026, 1:30 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.5 billion as of July 29, 2026. Its market cap has increased by 15.45% in one year.
Market Cap
2.50B
Enterprise Value
3.02B
Revenue
973.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.20
ChartMarket Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.50B, a decrease of -52.52%. That is a compound annual growth rate of -4.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.50B | 32.65% |
| Dec 31, 2025 | 1.88B | -28.33% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apex Biotechnology | 3.17B |
| Shine-On BioMedical | 3.14B |
| 3D Global Biotech | 3.09B |
| BRIM Biotechnology | 2.80B |
| Energenesis Biomedical CO.,LTD. | 2.80B |
| Intech Biopharm | 2.75B |
| GlycoNex Incorporation | 2.57B |
| Syngen Biotech | 2.39B |